Stem cell research key facts

Best places to work

The universities of Dundee and St Andrews are ranked among the top 10 best international academic institutions for scientists to work in

(Source : The Scientist)


Top 10 centre

Edinburgh BioQuarter, a landmark £600 million life sciences facility, makes Scotland one of the world’s top ten centres for biomedical commercialisation


Dundee uni top for research

Scotland is raising its profile in life sciences research − the University of Dundee produces more life sciences citations than Cambridge and Oxford, and is one of the leading scientific workplaces in the world

(Source : The Scientist)


Neurology centre

The Anne Rowling Regenerative Neurology Clinic focuses on multiple sclerosis, Alzheimer's, Parkinson's, Huntington's and Motor Neurone diseases research


Europe's largest

Scotland is home to Europe’s largest and most highly-regarded stem cell research community


Most research licences

Half of all UK stem cell research licences are issued to organisations in Scotland


World-class research

Scotland outperforms other countries in terms of stem cell research backed by its wealth of world-class medical schools and research centres


More medical research

Currently, more medical research is carried out per head of population in Scotland than anywhere else in Europe, easing the translation of stem cell research into clinical benefits


World leader

First in the world for stem cell research based citation impact – Scotland is at the forefront of stem cell research and regenerative medicine


3

The University of Edinburgh is ranked number three in the world for stem cell research based on citation impact

(Source : ScienceWatch)


200+

The Scottish Centre for Regenerative Medicine has over 200 scientists and clinicians, with on-site GMP development expertise, all based at Edinburgh BioQuarter


Specific expertise

Scotland has specific expertise in induced pluripotent stem cell (iPS) research and development, bone marrow derived mesenchymal stem cells, and embryonic stem cells


World's first

ReNeuron's groundbreaking Phase I trial using expanded neural stem cells in stroke patients is a world first. The stem cells are manufactured by Angel Biotechnology in Scotland.